Skip to main content
. Author manuscript; available in PMC: 2012 Jun 14.
Published in final edited form as: Cancer. 2010 Dec 14;117(11):10.1002/cncr.25791. doi: 10.1002/cncr.25791

Table 5 (b).

Median survival (95% confidence interval) divided by CLIP score and further by VEGF level (<450 vs. >450). The P-values correspond to a test comparing median survival VEGF-high and VEGF-low patients within the specified CLIP score, and the power indicates power to detect a significant difference given the observed sample sizes, assuming the true difference in median survival was the same as the observed difference in these data. Note how VEGF-high patients in a given CLIP group seem to have median survivals more similar to VEGF-low patients in the next CLIP group than VEGF-low patients in their own CLIP group.

all VEGF <450 VEGF >450
CLIP Median Survival Median Survival Median Survival
score n (months) n (months) n (months) P-value Power
0 55 37.0 (24.8-51.3) 48 37.5 (29.4-68.1) 7 19.5 (9.23-na) 0.10 0.14
1 75 23.1 (17.5-34.2) 64 23.1 (17.5-34.2) 11 18.1 (13.4-38.4) 0.50 0.08
2 77 11.7 (8.3-15.3) 62 12.4 (8.3-17.3) 15 9.6 (4.7-21.7) 0.23 0.10
3 53 7.6 (4.6-9.3) 40 7.8 (6.1-11.7) 13 3.6 (2.3-10.6) 0.05 0.48
4+ 25 2.5 (2.2-3.9) 15 4.4 (2.1-12.6) 10 2.5 (0.9-2.7) 0.05 0.17